Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-76881 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-76881, RRID:AB_11028278
- Product name
- Rabbit Polyclonal TRAILR3/TNFRSF10C Antibody
- Antibody type
- Polyclonal
- Description
- Peptide affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.
Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface.
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Nagane M, Shimizu S, Mori E, Kataoka S, Shiokawa Y
Neuro-oncology 2010 Jul;12(7):687-700
Neuro-oncology 2010 Jul;12(7):687-700
Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T
Cancer research 2008 Nov 1;68(21):8918-27
Cancer research 2008 Nov 1;68(21):8918-27
Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface.
Kawakubo T, Okamoto K, Iwata J, Shin M, Okamoto Y, Yasukochi A, Nakayama KI, Kadowaki T, Tsukuba T, Yamamoto K
Cancer research 2007 Nov 15;67(22):10869-78
Cancer research 2007 Nov 15;67(22):10869-78
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F, Liu X, Zhou Z, Yue P, Lotan R, Khuri FR, Chung LW, Sun SY
Cancer research 2005 Jul 15;65(14):6354-63
Cancer research 2005 Jul 15;65(14):6354-63
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa whole cell lysate with TRAIL-R3 antibody (ED) at 1:500 dilution.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.
